Vident Advisory’s Repligen RGEN Stock Holding History

Vident Advisory’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,333	Closed	-$546K	–	1528
2024 Q2	$546K	Sell	4,333 -451	-9%	-$70.7K	0.02%	832
2024 Q1	$880K	Buy	+4,784	New	+$911K	0.02%	622

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vident Advisory's RGEN Position: Q3 2024 in Review

Vident Advisory sold out of Repligen (RGEN) in Q3 2024, closing a stake of 4,333 shares — an estimated $546K sold.

Vident Advisory first reported a position in RGEN in Q1 2024 and held it in 2 quarters. The position peaked at $880K in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

Vident Advisory reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
Vident Advisory sold 4,333 Repligen shares in Q3 2024, an estimated $546K.
Vident Advisory first reported a position in Repligen in Q1 2024 and held it in 2 quarters.
Vident Advisory's Repligen position peaked at $880K in Q1 2024.
444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Vident Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.